Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levodopa versus rotigotine effects on stress hormones and nerve growth factor in Parkinson's disease
2010-022363-35Phase 4Active
- Sponsor
- St. Josef-Hospital Bochum
- Start
- Oct 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Parkinson's disease (PD) comparing Levodopa + benserazide, Rotigotine and Placebo (3 arms). Primary endpoint: Exploratory biomarker correlation. Started Oct 2010; status: active.
02
Drugs
levodopa + benseraziderotigotine
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on 2010-022363-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-022363-35.